|
Apr 18
|
Lilly Soars As Study Shows Weight-Loss Pill to Pass Ozempic
|
|
Apr 17
|
S&P 500 Gains and Losses Today: UnitedHealth Stock Drops After Earnings Miss, Guidance Cut
|
|
Apr 17
|
UnitedHealth Woes Aren’t Dragging Down the Entire Sector. Here’s Why.
|
|
Apr 17
|
How Eli Lilly's GLP-1 pill could transform the weight-loss space
|
|
Apr 17
|
Stocks Rebound Fizzles as Trump Goes on Offensive: Markets Wrap
|
|
Apr 17
|
Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill
|
|
Apr 17
|
Equity Markets Mixed as Trump Calls for Interest Rate Cuts
|
|
Apr 17
|
Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race
|
|
Apr 17
|
Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results
|
|
Apr 17
|
UnitedHealth Sell-Off Drags Dow Lower Intraday; Markets Weigh Trump's Remarks
|
|
Apr 17
|
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth
|
|
Apr 17
|
Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.
|
|
Apr 17
|
Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade
|
|
Apr 17
|
Eli Lilly (NYSE:LLY) Partners With BigHat And Achieves Phase 3 Success With Orforglipron
|
|
Apr 17
|
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
|
|
Apr 17
|
Top Stock Movers Now: UnitedHealth, Nvidia, Eli Lilly and More
|
|
Apr 17
|
Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial
|
|
Apr 17
|
Why Is Eli Lilly (LLY) Stock Rocketing Higher Today
|
|
Apr 17
|
Top Midday Stories: Google Found Liable on 3 of 4 Counts in Antitrust Case; UnitedHealth Shares Tumble on Revenue Miss, Guidance Cut
|
|
Apr 17
|
Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars
|